ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.71
0.01%
US Tech 100
18,056.80
-0.12%
다우존스 지수
39,940.30
0.18%
Bitcoin
66,849.82
2.47%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) 뉴스

MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MRNS
일자시간출처헤드라인심볼기업
2024/05/1720:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/1720:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/1720:00Business WireMarinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex ProgramNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/0820:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/0820:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/0820:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/0221:00Business WireMarinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/05/0121:00Business WireMarinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/04/1520:00Business WireMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/04/0605:00Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/03/2721:41Business WireMarinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant ReviewNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/03/0606:14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/03/0606:01Business WireMarinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2206:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2206:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2121:00Business WireMarinus Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/2021:00Business WireMarinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1706:00Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1506:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1505:07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1502:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1500:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1423:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/02/1402:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/01/2006:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/01/2006:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/01/2006:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
2024/01/2006:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:MRNS

최근 히스토리

COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
FX
USDGBP
US Dollar vs Sterling
AMEX
XLE
Energy Select Sector SPDR
NYSE
BAC
Bank of America
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유